Inhibition of intermediate-conductance Ca2+-activated K + channel and cytoprotective properties of 4-piperidinomethyl-2- isopropyl-5-methylphenol

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 5, 2007, Pages 679-685

  Shen, Ai Yu ^a   Tsai, Jen Hsiang ^a   Teng, Hsiu Chen ^a   Huang, Mei Han ^a   Wu, Sheng Nan ^b  

^a FOOYIN UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYL 2 BENZIMIDAZOLINONE; 4 PIPERIDINOMETHYL 2 ISOPROPYL 5 METHYLPHENOL; APAMIN; CLOTRIMAZOLE; CRESOL; IBERIOTOXIN; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MITOMYCIN; PAXILLINE; THYMOL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; IC 50; LEUKOCYTE; SICKLE CELL ANEMIA;

ANTIOXIDANTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGY; ERYTHROCYTES; GRANULOCYTES; HEMOLYSIS; HUMANS; INHIBITORY CONCENTRATION 50; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MITOMYCIN; PHENOLS; PIPERIDINES;

EID: 34447329069     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.5.0008     Document Type: Article

References (27)

1. Abdella, B. R., Fisher, J. (1985) A chemical perspective on the anthracycline antitumor antibiotics. Environ. Health Persp. 64: 4-18
2. + channel is essential for innate immunity. Nature 427: 853-858
3. Brugnara, C. (1997) Erythrocyte membrane transport physiology. Curr. Opin. Hematol. 4: 122-127
4. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 92: 520-526
5. Chiu, D., Lubin, B. (1979) Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: evidence for increased susceptibility to lipid peroxidation in vivo. J. Lab. Clin. Med. 94: 542-548
6. de Franceschi, L., Rouyer-Fessard, P., Alper, S. L., Jouault, H., Brugnara, C., Beuzard, Y. (1996) Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy. Blood 87: 1188-1195
7. Ca1 in human mast cells. FASEB J. 19: 1006-1008
8. 2+ levels of sickle cell anemia red cells. J. Clin. Invest. 92: 2489-2498
9. + channel. Eur. J. Pharmacol. 497: 1-6
10. Hebbel, R. P. (1991) Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 77: 214-237
11. Huang, M. H., Liao, L. F., Kuo, S. H., Chen, C. L., Shen, A. Y. (2005) Effects of 4-piperidinomethyl-2-isopropyl-5-methylphenol on oxidative stress and calcium current. J. Pharm. Pharmacol. 57: 1191-1198
12. + channel of intermediate conductance: a molecular target for novel treatments? Curr. Drug Targets 2: 401-422
13. Joiner, C. H., Morris, C. L., Cooper, E. S. (1993) Deoxygenation-induced cation fluxes in sickle cells. III. Cation selectivity and response to pH and membrane potential. Am. J. Physiol. 264: C734-744
14. Kok, L. D., Wong, Y. P., Wu, T. W., Chan, H. C., Kwok, T. T., Fung, K. P. (2000) Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs. Life Sci. 67: 91-99
15. Meadowcroft, A. M., Gilbert, C. J., Maravich-May, D., Hayward, S. L. (1998) Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy. Am. J. Health Syst. Pharm. 55: 1898-1902
16. Ohnishi, S. T., Ohnishi, T. (2001) In vitro effects of aged garlic extract and other nutritional supplements on sickle erythrocytes. J. Nutr. 131: 1085S-1092S
17. Ohnishi, S. T., Katagi, H., Katagi, C. (1989) Inhibition of the in vitro formation of dense cells and of irreversibly sickled cells by charybdotoxin, a specific inhibitor of calcium-activated potassium efflux. Biochim. Biophys. Acta. 1010: 199-203
18. Pawlowska, J., Tarasiuk, J., Wolf, C. R., Paine, M. J., Borowski, E. (2003) Differential ability of cytostatics from anthraquinone group to generate free radicals in three enzymatic systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase. Oncol. Res. 13: 245-252
19. Portzehl, H., Caldwell, P. C., Ruegg, J. C. (1964) The dependence of contraction and relaxation of muscle fibres from the crab Maia squinado on the internal concentration of free calcium ions. Biochim. Biophys. Acta 79: 581-591
20. Rice-Evans, C., Omorphos, S. C., Baysal, E. (1986) Sickle cell membranes and oxidative damage. Biochem. J. 237: 265-269
21. Schroder, E., Jonsson, T., Poole, L. (2003) The role of erythrocyte peroxiredoxin in detoxifying peroxides and in stimulating potassium efflux via the Gardos channels. Blood 101: 2897
22. Scott, M. D., van den Berg, J. J. M., Repka, T., Rouyer-Fessard, P., Hebbel, R. P., Beuzard, Y., Lubin, B. H. (1993) Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemic erythrocytes. J. Clin. Invest. 91: 1706-1712
23. + channels: molecular determinants and function of the SK family. Nat. Rev. Neurosci. 5: 758-770
24. + channels in granulocytes from a human cell line. J. Physiol. 472: 373-390
25. Vives-Corrons, J. L., Miguel-Garcia, A., Pujades, M. A., Miguel-Sosa, A., Cambiazzo, S., Linares, M., Dibarrart, M. T., Calvo, M. A. (1995) Increased susceptibility of microcytic red blood cells to in vitro oxidative stress. Eur. J. Haematol. 55: 327-331
26. + channels: physiological role and pharmacology. Curr. Med. Chem. 10: 649-661
27. 3 cells. Neuropharmacology 38: 979-989